youtube_live
Q2 2027 earnings • released • Revenue beat +1.92%
See resultschevron_right
4543:TYO
Terumo Corp
¥2,400.00
arrow_downward
-6.18%(-158.00) 1D
Nov 13, 3:30:00 PM GMT+9 · JPY
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4543...
Open
¥2,303
High
¥2,429
Low
¥2,280
Mkt. cap
3.55T
Avg. vol.
6.31M
Volume
13.59M
Dividend
1.25%
Quarterly dividend
¥8
Ex-dividend date
Sep 29, 2026
P/E ratio
21.53
52-wk high
¥2,689
52-wk low
¥1,900
EPS
¥111
Shares outstanding
370.59M
No. of employees
31K
Open
¥2,303
High
¥2,429
Low
¥2,280
Mkt. cap
3.55T
Avg. vol.
6.31M
Volume
13.59M
Dividend
1.25%
Quarterly dividend
¥8
Ex-dividend date
Sep 29, 2026
P/E ratio
21.53
52-wk high
¥2,689
52-wk low
¥1,900
EPS
¥111
Shares outstanding
370.59M
No. of employees
31K
News stories
From web sources and news partners
Seeking Alpha
·
8 hours ago
Terumo Corporation 2027 Q2 - Results - Earnings Call Presentation (OTCMKTS:TRUMY) 2026-11-13
Leelanau Ticker
·
19 hours ago
In Her Blood: Cedar Native Helms $1.5 Billion Company
Investing.com
·
19 hours ago
Why is Terumo stock sliding today?
Profile
Terumo Corporation was founded in 1921 as Red Line Thermometer Corporation by a group of medical scientists led by Dr. Kitasato Shibasaburō to produce medical thermometers in Japan.
The company's first product was "Jintan Taionkei", the first Japanese-made thermometer available for sale, and it has since expanded into a medical devices manufacturer, producing medical disposables, cardiovascular systems and diabetes care products.
In 1971, Terumo opened its first overseas office in the United States. Since then, the company has established subsidiaries in Europe, South America, China, India, Philippines, Vietnam, Thailand, Australia and México. The company later expanded its product range to include coronary stents and catheters, and acquired, among others, the cardiovascular specialty companies Vascutek and Microvention in 2002 and 2006 respectively. Wikipedia
About Terumo Corp
CEO-
Employees31.2K
FoundedSep 17, 1921
HeadquartersShibuya, Tokyo, Japan
SectorHealth Care
IndustryMedical device
Websiteterumo.co.jp
Last report
Nov 12, 2026
Fiscal period
Q2 2027
- Normalized EPS / Est. (JPY)
- GAAP EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
312.69B / 306.80B
Fiscal Q2 2027 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in JPY | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 274.96B | 296.63B | 300.32B | 311.81B |
Cost of goods sold | 127.97B | 143.44B | 149.06B | 133.27B |
Cost of revenue | 127.97B | 143.44B | 149.06B | 133.27B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 97.88B | 105.26B | 107.66B | 109.70B |
Operating expense | 101.90B | 109.31B | 98.62B | 89.06B |
Total operating expenses | 229.87B | 252.74B | 247.68B | 222.33B |
Operating income | 45.10B | 43.88B | 52.64B | 89.48B |
Other non operating income | -1.00M | 2.00M | -409.00M | -4.00M |
EBT including unusual items | 45.95B | 45.38B | 31.66B | 90.32B |
EBT excluding unusual items | 45.95B | 45.38B | 52.86B | 90.32B |
Income tax expense | 10.90B | 12.72B | 5.30B | 19.89B |
Effective tax rate | 23.72% | 28.04% | 16.73% | 22.03% |
Other operating expenses | 4.02B | 4.05B | -9.05B | -20.64B |
Net income | 35.05B | 32.65B | 26.37B | 70.43B |
Net profit margin | 12.75% | 11.01% | 8.78% | 22.59% |
Earnings per share | - | - | - | - |
Interest and investment income | 1.02B | 2.21B | - | 2.38B |
Interest expense | -18.00M | -463.00M | -1.32B | -1.48B |
Net interest expenses | 1.00B | 1.75B | -1.32B | 905.00M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 66.76B | 69.98B | 79.07B | 116.67B |
Gain or loss from assets sale | 4.72B | 154.00M | 188.00M | 12.00M |
Upcoming events